drugset / Trial / NCT00006218

3-AP in Treating Patients With Advanced Cancer

NCT00006218

Phase 1 Completed Vion Pharmaceuticals
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of 3-AP in treating patients who have advanced cancer.

Timeline

Start
2000-05
Primary completion
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Triapine Small molecule Intravenous

Indications

No indication recorded.